Probiotics in Gastroenterology

Gastroenterologists once defined gastrointestinal health as the absence of chronic disorder such as inflammatory bowel disease (IBD). However, this is too restrictive. The increasing frequency of digestive functional disorders, including non-ulcer dyspepsia and irritable bowel syndrome (IBS), justifies an enlargement of a definition that includes intestinal well-being and the overall impact on quality of life including reduction of disease risk. Some animal studies are required to investigate this concept. The intestinal microflora has been linked with a number of intestinal diseases including colon cancer, (IBS) and IBD however few details of their involvement have been elucidated. Since colon cancer and IBD can lead to extreme therapeutic approaches, including surgical excision, clarification of the role of the microflora in these diseases may significantly reduce morbidity

  • Prevention and treatment of Gastroenteritis
  • Treatment of Inflammatory Bowel Disease
  • Prevention of Ulcerative colitis
  • Reduction Lactose malabsorption
  • Prevention of Constipation
  • Gut related disorders

Related Conference of Probiotics in Gastroenterology

Probiotics in Gastroenterology Conference Speakers